Cargando…

Treatment of hidradenitis suppurativa resolves associated hematologic abnormalities

Detalles Bibliográficos
Autores principales:	Morss-Walton, Peyton C., Greif, Charlotte, Holcomb, Zachary E., Salian, Prerna, Yankama, Tuyen, Kim, Diana, Porter, Martina L., Kimball, Alexa B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Research Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112385/ https://www.ncbi.nlm.nih.gov/pubmed/35620032 http://dx.doi.org/10.1097/JW9.0000000000000011

Ejemplares similares

Methotrexate shows benefit in a subset of patients with severe hidradenitis suppurativa
por: Savage, Kevin T., et al.
Publicado: (2020)

Travel burden on patients at a subspecialty hidradenitis suppurativa clinic: a single-center retrospective study
por: Kim, Diana S., et al.
Publicado: (2022)

Risk of COVID-19 in dermatologic patients receiving long-term immunomodulatory therapy
por: Holcomb, Zachary E., et al.
Publicado: (2020)

TNF-α inhibitors in the treatment of hidradenitis suppurativa
por: Savage, Kevin T., et al.
Publicado: (2019)

Response to: Remission of hidradenitis suppurativa after bariatric surgery
por: Golbari, Nicole Mona, et al.
Publicado: (2018)

33892 Telehealth use at a specialty hidradenitis suppurativa clinic during the COVID-19 pandemic
por: Kim, Diana S., et al.
Publicado: (2022)

Erythrocyte sedimentation rate, rather than C-reactive protein, may be the preferred biomarker for hidradenitis suppurativa
por: Gibson, Ruby S., et al.
Publicado: (2022)

Tofacitinib shows benefit in conjunction with other therapies in recalcitrant hidradenitis suppurativa patients
por: Savage, Kevin T., et al.
Publicado: (2020)

Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations
por: Garg, Amit, et al.
Publicado: (2022)

Hidradenitis suppurativa in AIDS
por: Khambhati, Ravi, et al.
Publicado: (2010)

Hidradenitis suppurativa and intimacy
por: Jemec, G.
Publicado: (2018)

Coexistence of Hidradenitis Suppurativa and Steatocystoma Multiplex: Is It a New Variant of Hidradenitis Suppurativa?
por: Fletcher, Joshua, et al.
Publicado: (2021)

Surgical Management of Hidradenitis Suppurativa
por: Menderes, Adnan, et al.
Publicado: (2010)

Hidradenitis Suppurativa: Inside and Out
por: Patil, Sharmila, et al.
Publicado: (2018)

Multimodal management of hidradenitis suppurativa
por: Jemec, Gregor B.E.
Publicado: (2020)

Leflunomide-Induced Hidradenitis Suppurativa
por: Machan, Achraf, et al.
Publicado: (2020)

Secondary prevention of hidradenitis suppurativa
por: Kurzen, Hjalmar, et al.
Publicado: (2019)

Facklamia hominis in hidradenitis suppurativa
por: Basal, Yasmeen, et al.
Publicado: (2021)

Management of Severe Hidradenitis Suppurativa
por: Katzman, Ju Hee, et al.
Publicado: (2021)

Vulvar cancer in hidradenitis suppurativa
por: Vergeldt, T.F.M., et al.
Publicado: (2022)

Surgical Treatment in Hidradenitis Suppurativa
por: Shukla, Ratnakar, et al.
Publicado: (2022)

Surgical management of hidradenitis suppurativa
por: Gierek, Marcin, et al.
Publicado: (2022)

Hydroxychloroquine for the treatment of hidradenitis suppurativa
por: Brant, Elena Gonzalez, et al.
Publicado: (2023)

Certolizumab to treat hidradenitis suppurativa
por: Shadid, Asem, et al.
Publicado: (2022)

Dietary Factors and Hidradenitis Suppurativa
por: Shen, Alan S., et al.
Publicado: (2023)

Postoperative Quality of Life in Patients with Hidradenitis Suppurativa Utilizing the Hidradenitis Suppurativa Burden of Disease Tool
por: Guart, Jiddu A, et al.
Publicado: (2021)

An assessment of the relative impact of hidradenitis suppurativa, psoriasis, and obesity on quality of life()()
por: Storer, M.A., et al.
Publicado: (2018)

Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa
por: Gulliver, Wayne, et al.
Publicado: (2016)

Association of hidradenitis suppurativa disease severity with increased risk for systemic comorbidities
por: Crowley, JJ, et al.
Publicado: (2014)

Obstacles to Early Diagnosis and Treatment of Hidradenitis Suppurativa: Current Perspectives on Improving Clinical Management
por: Snyder, Corey L, et al.
Publicado: (2023)

Imaging of Hidradenitis Suppurativa and Its Complications
por: Poh, Feng, et al.
Publicado: (2014)

Renal amyloidosis secondary to hidradenitis suppurativa
por: Ilgen, Ufuk, et al.
Publicado: (2013)

Update on hidradenitis suppurativa: connecting the tracts
por: Gill, Liza, et al.
Publicado: (2014)

Compartmentalized Cytokine Responses in Hidradenitis Suppurativa
por: Kanni, Theodora, et al.
Publicado: (2015)

Ertapenem rescue therapy in hidradenitis suppurativa
por: Chahine, Adam A., et al.
Publicado: (2018)

Hidradenitis suppurativa – known and unknown disease
por: Wieczorek, Marta, et al.
Publicado: (2018)

Secukinumab and hidradenitis suppurativa: Friends or foes?
por: Marasca, Claudio, et al.
Publicado: (2019)

Hidradenitis suppurativa: an update on connecting the tracts
por: Smith, Mallory K, et al.
Publicado: (2017)

A severe case of hidradenitis suppurativa
por: Cubas, Vanessa, et al.
Publicado: (2016)

Special considerations for women with hidradenitis suppurativa
por: Collier, Erin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g379cl4q6j06o5jco2t10iuagl